Andrey Santos1, Daniéla Oliveira Magro2, Rosana Evangelista-Poderoso3, Mario José Abdalla Saad4. 1. Department of Internal Medicine-FCM, State University of Campinas-UNICAMP, Campinas, SP, Brazil. 2. Department of Surgery, Faculty of Medical Sciences, State University of Campinas-UNICAMP, Campinas, SP, Brazil. 3. Faculty of Medical Sciences, State University of Campinas-UNICAMP, Campinas, SP, Brazil. 4. Department of Internal Medicine-FCM, State University of Campinas-UNICAMP, Campinas, SP, Brazil. msaad@fcm.unicamp.br.
Abstract
BACKGROUND: Our understanding of the pathophysiology of the COVID-19 manifestations and evolution has improved over the past 10 months, but the reasons why evolution is more severe in obese and diabetic patients are not yet completely understood. MAIN TEXT: In the present review we discuss the different mechanisms that may contribute to explain the pathophysiology of COVID-19 including viral entrance, direct viral toxicity, endothelial dysfunction, thromboinflammation, dysregulation of the immune response, and the renin-angiotensin-aldosterone system. CONCLUSIONS: We show that the viral infection activates an integrated stress response, including activations of serine kinases such as PKR and PERK, which induce IRS-1 serine phosphorylation and insulin resistance. In parallel, we correlate and show the synergy of the insulin resistance of COVID-19 with this hormonal resistance of obesity and diabetes, which increase the severity of the disease. Finally, we discuss the potential beneficial effects of drugs used to treat insulin resistance and diabetes in patients with COVID-19.
BACKGROUND: Our understanding of the pathophysiology of the COVID-19 manifestations and evolution has improved over the past 10 months, but the reasons why evolution is more severe in obese and diabetic patients are not yet completely understood. MAIN TEXT: In the present review we discuss the different mechanisms that may contribute to explain the pathophysiology of COVID-19 including viral entrance, direct viral toxicity, endothelial dysfunction, thromboinflammation, dysregulation of the immune response, and the renin-angiotensin-aldosterone system. CONCLUSIONS: We show that the viral infection activates an integrated stress response, including activations of serine kinases such as PKR and PERK, which induce IRS-1 serine phosphorylation and insulin resistance. In parallel, we correlate and show the synergy of the insulin resistance of COVID-19 with this hormonal resistance of obesity and diabetes, which increase the severity of the disease. Finally, we discuss the potential beneficial effects of drugs used to treat insulin resistance and diabetes in patients with COVID-19.
Authors: Mitsugu Shimobayashi; Verena Albert; Bettina Woelnerhanssen; Irina C Frei; Diana Weissenberger; Anne Christin Meyer-Gerspach; Nicolas Clement; Suzette Moes; Marco Colombi; Jerome A Meier; Marta M Swierczynska; Paul Jenö; Christoph Beglinger; Ralph Peterli; Michael N Hall Journal: J Clin Invest Date: 2018-03-12 Impact factor: 14.808
Authors: Victor G Puelles; Marc Lütgehetmann; Maja T Lindenmeyer; Jan P Sperhake; Milagros N Wong; Lena Allweiss; Silvia Chilla; Axel Heinemann; Nicola Wanner; Shuya Liu; Fabian Braun; Shun Lu; Susanne Pfefferle; Ann S Schröder; Carolin Edler; Oliver Gross; Markus Glatzel; Dominic Wichmann; Thorsten Wiech; Stefan Kluge; Klaus Pueschel; Martin Aepfelbacher; Tobias B Huber Journal: N Engl J Med Date: 2020-05-13 Impact factor: 91.245
Authors: Behnood Bikdeli; Mahesh V Madhavan; Aakriti Gupta; David Jimenez; John R Burton; Caroline Der Nigoghossian; Taylor Chuich; Shayan Nabavi Nouri; Isaac Dreyfus; Elissa Driggin; Sanjum Sethi; Kartik Sehgal; Saurav Chatterjee; Walter Ageno; Mohammad Madjid; Yutao Guo; Liang V Tang; Yu Hu; Laurent Bertoletti; Jay Giri; Mary Cushman; Isabelle Quéré; Evangelos P Dimakakos; C Michael Gibson; Giuseppe Lippi; Emmanuel J Favaloro; Jawed Fareed; Alfonso J Tafur; Dominic P Francese; Jaya Batra; Anna Falanga; Kevin J Clerkin; Nir Uriel; Ajay Kirtane; Claire McLintock; Beverley J Hunt; Alex C Spyropoulos; Geoffrey D Barnes; John W Eikelboom; Ido Weinberg; Sam Schulman; Marc Carrier; Gregory Piazza; Joshua A Beckman; Martin B Leon; Gregg W Stone; Stephan Rosenkranz; Samuel Z Goldhaber; Sahil A Parikh; Manuel Monreal; Harlan M Krumholz; Stavros V Konstantinides; Jeffrey I Weitz; Gregory Y H Lip Journal: Thromb Haemost Date: 2020-05-30 Impact factor: 5.249
Authors: Cara B Ebbeling; Amy Knapp; Ann Johnson; Julia M W Wong; Kimberly F Greco; Clement Ma; Samia Mora; David S Ludwig Journal: Am J Clin Nutr Date: 2022-01-11 Impact factor: 7.045
Authors: Caio Oliveira de Sá-Ferreira; Camila Helena Macedo da Costa; João Campos Wiltgen Guimarães; Nathasha Souza Sampaio; Leticia de Moraes Lopes Silva; Larissa Paula de Mascarenhas; Nicollas Garcia Rodrigues; Talita Labonia Dos Santos; Solange Campos; Esther Cytrynbaum Young Journal: Am J Physiol Endocrinol Metab Date: 2021-11-15 Impact factor: 4.310
Authors: Miguel Angel Casillas Santana; Juan Antonio Arreguín Cano; Alejandro Dib Kanán; Farid Alonso Dipp Velázquez; Paulina Del Carmen Sosa Munguía; Gabriel Alejandro Martínez Castañón; Brenda Eréndida Castillo Silva; Carolina Sámano Valencia; Marco Felipe Salas Orozco Journal: Medicina (Kaunas) Date: 2021-05-13 Impact factor: 2.430
Authors: Thais de Cássia Negrini; Iracilda Zeppone Carlos; Cristiane Duque; Karina Sampaio Caiaffa; Rodrigo Alex Arthur Journal: Front Oral Health Date: 2021-09-09